Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Henrik Zecha"'
Autor:
Henning Plage, Kira Furlano, Jörg Neymeyer, Sarah Weinberger, Benedikt Gerdes, Mandy Hubatsch, Bernhard Ralla, Antonia Franz, Annika Fendler, Michela deMartino, Florian Roßner, Simon Schallenberg, Sefer Elezkurtaj, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, Joachim Weischenfeldt, Tobias Klatte, Thorsten Schlomm, David Horst, Henrik Zecha, Marcin Slojewski
Publikováno v:
BJUI Compass, Vol 5, Iss 6, Pp 585-592 (2024)
Abstract Objectives Carcinoembryonic antigen (CEA) is a cell surface glycoprotein that represents a promising therapeutic target. Serum measurement of shedded CEA can be utilized for monitoring of cancer patients. Material and Methods To evaluate the
Externí odkaz:
https://doaj.org/article/81a61db9b6264355b1ed85e97fb6d1fe
Autor:
Henning Plage, Kira Furlano, Sebastian Hofbauer, Sarah Weinberger, Bernhard Ralla, Antonia Franz, Annika Fendler, Michela de Martino, Florian Roßner, Sefer Elezkurtaj, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Henrik Zecha, Sarah Minner, Ronald Simon, Guido Sauter, Joachim Weischenfeldt, Tobias Klatte, Thorsten Schlomm, David Horst, Simon Schallenberg
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background A high level of PD-L1 expression is the most relevant predictive parameter for response to immune checkpoint inhibitor (CPI) therapy in urinary bladder cancer. Existing data on the relationship between PD-L1 expression and the nat
Externí odkaz:
https://doaj.org/article/2e11c11592e44f26b250abef630710aa
Autor:
Jan H. Müller, Henning Plage, Sefer Elezkurtaj, Tim Mandelkow, Zhihao Huang, Magalie C. J. Lurati, Jonas B. Raedler, Nicolaus F. Debatin, Eik Vettorazzi, Henrik Samtleben, Sebastian Hofbauer, Kira Furlano, Jörg Neymeyer, Irena Goranova, Bernhard Ralla, Sarah Weinberger, David Horst, Florian Roßner, Simon Schallenberg, Andreas H. Marx, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Maximilian Lennartz, Sarah Minner, Ronald Simon, Guido Sauter, Henrik Zecha, Thorsten Schlomm, Elena Bady
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
IntroductionTrophoblast cell surface antigen 2 (TROP2; EpCAM2) is a transmembrane glycoprotein which is closely related to EpCAM (EpCAM; EpCAM1). Both proteins share partial overlapping functions in epithelial development and EpCAM expression but hav
Externí odkaz:
https://doaj.org/article/e1665b34d1bc44738c48bdeeea0208d5
Autor:
Paul Giacomo Bruch, Henning Plage, Sebastian Hofbauer, Kira Kornienko, Sarah Weinberger, Florian Roßner, Simon Schallenberg, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, Henrik Zecha, Tobias Klatte, Thorsten Schlomm, David Horst, Sefer Elezkurtaj
Publikováno v:
Experimental and Molecular Pathology. 131:104860
Autor:
Henning Plage, Henrik Samtleben, Sebastian Hofbauer, Kira Kornienko, Sarah Weinberger, Paul Giacomo Bruch, Sefer Elezkurtaj, Florian Roßner, Simon Schallenberg, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, Tobias Klatte, Thorsten Schlomm, David Horst, Henrik Zecha
Publikováno v:
Human pathology. 130
The transcription factor GATA binding protein 3 (GATA3) is commonly used in surgical pathology as a diagnostic marker to distinguish urothelial carcinomas from other cancer entities. However, the clinical relevance of GATA3 expression in urothelial b
Autor:
Michael Rink, Ronald Simon, Niclas C Blessin, Martina Kluth, Linnea Lindhorst, Roland Dahlem, Till Krech, Till S. Clauditz, Guido Sauter, Wolfgang Höppner, Till Eichenauer, Henrik Zecha, Margit Fisch, Franziska Büscheck, Katharina Möller, Stefan Steurer, Cord Matthies, Christoph Fraune, Claudia Hube-Magg, Ousman Doh, Maximilian Lennartz, Silke Riechardt, Andreas H. Marx
Publikováno v:
International Urology and Nephrology
Background PD-L1 expression predicts response to immune checkpoint inhibitors in renal cell carcinomas (RCC), but has also been suggested to be linked to poor patient outcome. Methods We analyzed PD-L1 in > 1400 RCC in a tissue microarray format by i
Autor:
Hendrik Isbarn, Henrik Zecha, Uwe Pichlmeier, Petra Anheuser, Klaus-Peter Dieckmann, Magdalena Kulejewski, Hanna Simonsen-Richter
Publikováno v:
BioMed Research International, Vol 2019 (2019)
BioMed Research International
BioMed Research International
Introduction. Although serum tumor markers beta human chorionic gonadotropin (bHCG), alpha-fetoprotein (AFP), and lactate dehydrogenase (LDH) are well-established tools for the management of testicular germ cell tumours (GCTs), there are only few dat
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jawid Habibzada, Nina Harke, Jorn H. Witt, Katarina Urbanova, Christian Wagner, Mustapha Addali, Henrik Zecha, Michael Godes
Publikováno v:
World Journal of Urology. 35:389-394
To evaluate the impact of the type of urinary diversion (suprapubic vs. transurethral catheterization) on patients' postoperative pain after radical prostatectomy, development of bacteriuria and long-term functional results.A randomized, prospective
Autor:
Cord Matthies, Petra Anheuser, Henrik Zecha, Christian Ruf, Klaus-Peter Dieckmann, Tim Nestler, Stefan Borck, Hendrik Isbarn
Publikováno v:
Journal of cancer research and clinical oncology. 145(9)
Clinical stage (CS) 1 testicular seminoma is cured in almost 100% of cases following either retroperitoneal radiotherapy, carboplatin monotherapy, or surveillance strategies. Little is known about potential long-term effects of carboplatin. We, there